Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Inventory Average (2016 - 2026)

Tandem Diabetes Care filings provide 12 years of Inventory Average readings, the most recent being $133.0 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 11.92% to $133.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $133.0 million, a 11.92% decrease, with the full-year FY2025 number at $139.2 million, down 9.48% from a year prior.
  • Inventory Average hit $133.0 million in Q4 2025 for Tandem Diabetes Care, down from $139.9 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $157.8 million in Q2 2024 to a low of $65.3 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $136.3 million (2023), compared with a mean of $118.4 million.
  • Biggest five-year swings in Inventory Average: surged 66.08% in 2023 and later decreased 11.92% in 2025.
  • Tandem Diabetes Care's Inventory Average stood at $67.1 million in 2021, then skyrocketed by 60.77% to $107.9 million in 2022, then surged by 39.62% to $150.7 million in 2023, then increased by 0.21% to $151.0 million in 2024, then dropped by 11.92% to $133.0 million in 2025.
  • The last three reported values for Inventory Average were $133.0 million (Q4 2025), $139.9 million (Q3 2025), and $141.9 million (Q2 2025) per Business Quant data.